Based on 6 analysts giving stock ratings to Aura Biosciences Inc in the past month.
In the current month, AURA has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AURA average Analyst price target in the last month is 16.600.
Based on analysts' estimates, AURA EPS is projected to reach -0.368 in FY2026Q3, following reported EPS of -0.481 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.48, while Aura Biosciences IncAURA's earnings per share (EPS) for the previous quarter was USD -0.50. EPS for the next quarter is expected at USD -0.37.